Loading…
Editorial: HBeAg seroconversion is not sufficient to allow cessation of nucleos(t)ide analogue treatment in Caucasian hepatitis B patients
Linked Content This article is linked to Van Hees et al paper. To view this article visit https://doi.org/10.1111/apt.14560.
Saved in:
| Published in: | Alimentary pharmacology & therapeutics 2018-06, Vol.47 (11), p.1551-1552 |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | |
|---|---|
| cites | |
| container_end_page | 1552 |
| container_issue | 11 |
| container_start_page | 1551 |
| container_title | Alimentary pharmacology & therapeutics |
| container_volume | 47 |
| creator | Ingiliz, P. Canbay, A. |
| description | Linked Content
This article is linked to Van Hees et al paper. To view this article visit https://doi.org/10.1111/apt.14560. |
| doi_str_mv | 10.1111/apt.14649 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2051667419</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2047366309</sourcerecordid><originalsourceid>FETCH-LOGICAL-p3149-d981d95a46c779cd17cd3fab37ae475366b38a2b2cc784ce92ba1c54c60d86623</originalsourceid><addsrcrecordid>eNpdkc1u1TAQhS1ERS-FBS-ALLFpF2n9Fydmd3tVKFKlsijraOJMiitfO8QOVV-Bp67TFhbMZkaab2Z05hDygbNTXuIMpnzKlVbmFdlwqetKMKlfkw0T2lSi5fKQvE3pjjGmGybekENh2qZVot2QPxeDy3F24D_Ty3Pc3tKEc7Qx_MY5uRioSzTETNMyjs46DJnmSMH7eE8tpgR5heJIw2I9xnScT9yAFAL4eLsgzTNC3q9jLtAdLBaSg0B_4lQmc1l-TteqAOkdORjBJ3z_ko_Ijy8XN7vL6ur667fd9qqaJFemGkzLB1OD0rZpjB14Ywc5Qi8bQNXUUutetiB6YW3RaNGIHritldVsaLUW8ogcP--d5vhrwZS7vUsWvYeAcUmdYDXXulHcFPTTf-hdXOaibaVUU25JtlIfX6il3-PQTbPbw_zQ_f1yAc6egXvn8eFfn7Nuta8r9nVP9nXb7zdPhXwEpyeODA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2047366309</pqid></control><display><type>article</type><title>Editorial: HBeAg seroconversion is not sufficient to allow cessation of nucleos(t)ide analogue treatment in Caucasian hepatitis B patients</title><source>Wiley</source><creator>Ingiliz, P. ; Canbay, A.</creator><creatorcontrib>Ingiliz, P. ; Canbay, A.</creatorcontrib><description>Linked Content
This article is linked to Van Hees et al paper. To view this article visit https://doi.org/10.1111/apt.14560.</description><identifier>ISSN: 0269-2813</identifier><identifier>EISSN: 1365-2036</identifier><identifier>DOI: 10.1111/apt.14649</identifier><identifier>PMID: 29878428</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Hepatitis ; Hepatitis B ; Hepatitis B e antigen ; Seroconversion</subject><ispartof>Alimentary pharmacology & therapeutics, 2018-06, Vol.47 (11), p.1551-1552</ispartof><rights>2018 John Wiley & Sons Ltd</rights><rights>Copyright © 2018 John Wiley & Sons Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0001-6069-7899 ; 0000-0001-7218-4548</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29878428$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ingiliz, P.</creatorcontrib><creatorcontrib>Canbay, A.</creatorcontrib><title>Editorial: HBeAg seroconversion is not sufficient to allow cessation of nucleos(t)ide analogue treatment in Caucasian hepatitis B patients</title><title>Alimentary pharmacology & therapeutics</title><addtitle>Aliment Pharmacol Ther</addtitle><description>Linked Content
This article is linked to Van Hees et al paper. To view this article visit https://doi.org/10.1111/apt.14560.</description><subject>Hepatitis</subject><subject>Hepatitis B</subject><subject>Hepatitis B e antigen</subject><subject>Seroconversion</subject><issn>0269-2813</issn><issn>1365-2036</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNpdkc1u1TAQhS1ERS-FBS-ALLFpF2n9Fydmd3tVKFKlsijraOJMiitfO8QOVV-Bp67TFhbMZkaab2Z05hDygbNTXuIMpnzKlVbmFdlwqetKMKlfkw0T2lSi5fKQvE3pjjGmGybekENh2qZVot2QPxeDy3F24D_Ty3Pc3tKEc7Qx_MY5uRioSzTETNMyjs46DJnmSMH7eE8tpgR5heJIw2I9xnScT9yAFAL4eLsgzTNC3q9jLtAdLBaSg0B_4lQmc1l-TteqAOkdORjBJ3z_ko_Ijy8XN7vL6ur667fd9qqaJFemGkzLB1OD0rZpjB14Ywc5Qi8bQNXUUutetiB6YW3RaNGIHritldVsaLUW8ogcP--d5vhrwZS7vUsWvYeAcUmdYDXXulHcFPTTf-hdXOaibaVUU25JtlIfX6il3-PQTbPbw_zQ_f1yAc6egXvn8eFfn7Nuta8r9nVP9nXb7zdPhXwEpyeODA</recordid><startdate>201806</startdate><enddate>201806</enddate><creator>Ingiliz, P.</creator><creator>Canbay, A.</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>7T5</scope><scope>7TK</scope><scope>7U9</scope><scope>H94</scope><scope>M7N</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6069-7899</orcidid><orcidid>https://orcid.org/0000-0001-7218-4548</orcidid></search><sort><creationdate>201806</creationdate><title>Editorial: HBeAg seroconversion is not sufficient to allow cessation of nucleos(t)ide analogue treatment in Caucasian hepatitis B patients</title><author>Ingiliz, P. ; Canbay, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p3149-d981d95a46c779cd17cd3fab37ae475366b38a2b2cc784ce92ba1c54c60d86623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Hepatitis</topic><topic>Hepatitis B</topic><topic>Hepatitis B e antigen</topic><topic>Seroconversion</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ingiliz, P.</creatorcontrib><creatorcontrib>Canbay, A.</creatorcontrib><collection>PubMed</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Alimentary pharmacology & therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ingiliz, P.</au><au>Canbay, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Editorial: HBeAg seroconversion is not sufficient to allow cessation of nucleos(t)ide analogue treatment in Caucasian hepatitis B patients</atitle><jtitle>Alimentary pharmacology & therapeutics</jtitle><addtitle>Aliment Pharmacol Ther</addtitle><date>2018-06</date><risdate>2018</risdate><volume>47</volume><issue>11</issue><spage>1551</spage><epage>1552</epage><pages>1551-1552</pages><issn>0269-2813</issn><eissn>1365-2036</eissn><abstract>Linked Content
This article is linked to Van Hees et al paper. To view this article visit https://doi.org/10.1111/apt.14560.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>29878428</pmid><doi>10.1111/apt.14649</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0001-6069-7899</orcidid><orcidid>https://orcid.org/0000-0001-7218-4548</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0269-2813 |
| ispartof | Alimentary pharmacology & therapeutics, 2018-06, Vol.47 (11), p.1551-1552 |
| issn | 0269-2813 1365-2036 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2051667419 |
| source | Wiley |
| subjects | Hepatitis Hepatitis B Hepatitis B e antigen Seroconversion |
| title | Editorial: HBeAg seroconversion is not sufficient to allow cessation of nucleos(t)ide analogue treatment in Caucasian hepatitis B patients |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T17%3A17%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Editorial:%20HBeAg%20seroconversion%20is%20not%20sufficient%20to%20allow%20cessation%20of%20nucleos(t)ide%20analogue%20treatment%20in%20Caucasian%20hepatitis%20B%20patients&rft.jtitle=Alimentary%20pharmacology%20&%20therapeutics&rft.au=Ingiliz,%20P.&rft.date=2018-06&rft.volume=47&rft.issue=11&rft.spage=1551&rft.epage=1552&rft.pages=1551-1552&rft.issn=0269-2813&rft.eissn=1365-2036&rft_id=info:doi/10.1111/apt.14649&rft_dat=%3Cproquest_pubme%3E2047366309%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p3149-d981d95a46c779cd17cd3fab37ae475366b38a2b2cc784ce92ba1c54c60d86623%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2047366309&rft_id=info:pmid/29878428&rfr_iscdi=true |